Ignite Creation Date:
2024-10-25 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06637150
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-28
Brief Title:
Dalpicilib-Enhanced Vs Standard Endocrine Therapy in ER HER2- Early Breast Cancer
Sponsor:
Organization:
None